vs
牛津地产（IIPR）与STEM, INC.（STEM）财务数据对比。点击上方公司名可切换其他公司
牛津地产的季度营收约是STEM, INC.的1.4倍（$66.7M vs $47.1M），牛津地产净利率更高（47.8% vs -33.9%，领先81.7%），牛津地产同比增速更快（-13.1% vs -15.6%），过去两年STEM, INC.的营收复合增速更高（36.1% vs -6.0%）
牛津地产是一家加拿大跨国企业，业务涵盖房地产投资、开发与物业管理。其投资组合包含写字楼、零售、工业、多户住宅、生命科学及酒店类资产。该公司1960年以私营企业形式创立，自2003年起成为安大略省市政雇员退休系统（OMERS）的全资子公司，总部设于多伦多，在纽约、伦敦、澳大利亚、新加坡及卢森堡均设有区域总部。
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
IIPR vs STEM — 直观对比
营收规模更大
IIPR
是对方的1.4倍
$47.1M
营收增速更快
IIPR
高出2.4%
-15.6%
净利率更高
IIPR
高出81.7%
-33.9%
两年增速更快
STEM
近两年复合增速
-6.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.7M | $47.1M |
| 净利润 | $31.8M | $-16.0M |
| 毛利率 | — | 48.9% |
| 营业利润率 | 47.8% | -17.7% |
| 净利率 | 47.8% | -33.9% |
| 营收同比 | -13.1% | -15.6% |
| 净利润同比 | -20.4% | 68.8% |
| 每股收益（稀释后） | $1.07 | $-4.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IIPRSTEM
| Q4 25 | $66.7M | $47.1M | ||
| Q3 25 | $64.7M | $38.2M | ||
| Q2 25 | $62.9M | $38.4M | ||
| Q1 25 | $71.7M | $32.5M | ||
| Q4 24 | $76.7M | $55.8M | ||
| Q3 24 | $76.5M | $29.3M | ||
| Q2 24 | $79.8M | $34.0M | ||
| Q1 24 | $75.5M | $25.5M |
净利润IIPRSTEM
| Q4 25 | $31.8M | $-16.0M | ||
| Q3 25 | $29.3M | $-23.8M | ||
| Q2 25 | $26.0M | $202.5M | ||
| Q1 25 | $31.1M | $-25.0M | ||
| Q4 24 | $40.0M | $-51.1M | ||
| Q3 24 | $40.2M | $-148.3M | ||
| Q2 24 | $42.0M | $-582.3M | ||
| Q1 24 | $39.4M | $-72.3M |
毛利率IIPRSTEM
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
营业利润率IIPRSTEM
| Q4 25 | 47.8% | -17.7% | ||
| Q3 25 | 45.5% | -33.6% | ||
| Q2 25 | 45.9% | -34.8% | ||
| Q1 25 | 47.4% | -65.0% | ||
| Q4 24 | 54.7% | -84.4% | ||
| Q3 24 | 54.8% | -493.2% | ||
| Q2 24 | 53.1% | -1705.5% | ||
| Q1 24 | 55.7% | -267.0% |
净利率IIPRSTEM
| Q4 25 | 47.8% | -33.9% | ||
| Q3 25 | 45.3% | -62.2% | ||
| Q2 25 | 41.4% | 527.8% | ||
| Q1 25 | 43.3% | -76.9% | ||
| Q4 24 | 52.2% | -91.6% | ||
| Q3 24 | 52.6% | -506.3% | ||
| Q2 24 | 52.6% | -1712.6% | ||
| Q1 24 | 52.3% | -283.9% |
每股收益（稀释后）IIPRSTEM
| Q4 25 | $1.07 | $-4.40 | ||
| Q3 25 | $0.97 | $-2.84 | ||
| Q2 25 | $0.86 | $-1.79 | ||
| Q1 25 | $1.03 | $-0.15 | ||
| Q4 24 | $1.35 | $-15.29 | ||
| Q3 24 | $1.37 | $-18.24 | ||
| Q2 24 | $1.44 | $-71.81 | ||
| Q1 24 | $1.36 | $-0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $47.6M | $48.9M |
| 总债务越低越好 | $393.7M | — |
| 股东权益账面价值 | $1.8B | $-249.4M |
| 总资产 | $2.4B | $308.9M |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
现金及短期投资IIPRSTEM
| Q4 25 | $47.6M | $48.9M | ||
| Q3 25 | $41.9M | $43.1M | ||
| Q2 25 | $104.9M | $40.8M | ||
| Q1 25 | $133.3M | $58.6M | ||
| Q4 24 | $151.2M | $56.3M | ||
| Q3 24 | $172.4M | $75.4M | ||
| Q2 24 | $160.9M | $89.6M | ||
| Q1 24 | $173.5M | $112.8M |
总债务IIPRSTEM
| Q4 25 | $393.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IIPRSTEM
| Q4 25 | $1.8B | $-249.4M | ||
| Q3 25 | $1.9B | $-235.7M | ||
| Q2 25 | $1.9B | $-214.1M | ||
| Q1 25 | $1.9B | $-417.5M | ||
| Q4 24 | $1.9B | $-398.4M | ||
| Q3 24 | $1.9B | $-344.1M | ||
| Q2 24 | $1.9B | $-203.2M | ||
| Q1 24 | $2.0B | $371.6M |
总资产IIPRSTEM
| Q4 25 | $2.4B | $308.9M | ||
| Q3 25 | $2.3B | $362.6M | ||
| Q2 25 | $2.3B | $379.2M | ||
| Q1 25 | $2.4B | $405.1M | ||
| Q4 24 | $2.4B | $437.4M | ||
| Q3 24 | $2.4B | $537.8M | ||
| Q2 24 | $2.4B | $691.5M | ||
| Q1 24 | $2.4B | $1.3B |
负债/权益比IIPRSTEM
| Q4 25 | 0.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $198.2M | $8.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 6.22× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流IIPRSTEM
| Q4 25 | $198.2M | $8.2M | ||
| Q3 25 | $45.6M | $11.4M | ||
| Q2 25 | $48.4M | $-21.3M | ||
| Q1 25 | $54.2M | $8.5M | ||
| Q4 24 | $258.4M | $-14.7M | ||
| Q3 24 | $64.9M | $-9.4M | ||
| Q2 24 | $64.2M | $-11.9M | ||
| Q1 24 | $71.6M | $-621.0K |
现金转化率IIPRSTEM
| Q4 25 | 6.22× | — | ||
| Q3 25 | 1.56× | — | ||
| Q2 25 | 1.86× | -0.11× | ||
| Q1 25 | 1.75× | — | ||
| Q4 24 | 6.46× | — | ||
| Q3 24 | 1.61× | — | ||
| Q2 24 | 1.53× | — | ||
| Q1 24 | 1.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
